drugset / Trial / NCT07713134

Comparison of the Efficacy and Safety of Oliceridine and Sufentanil in Patients Undergoing Outpatient Hysteroscopy

NCT07713134

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study aimed to investigate the safety and efficacy of oliceridine compared with sufentanil in outpatient hysteroscopy.

Timeline

Start
2025-08-01
Primary completion
2026-05-20
Completion
2026-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Oliceridine Other / unclassified 0.04 mg/kg
Comparator Sufentanil Other / unclassified 0.15 ug/kg

Indications

No indication recorded.